| Serial Number | 90406176 |
| Word Mark | PDMO |
| Filing Date | Wednesday, December 23, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 29, 2022 |
| Registration Number | 6909412 |
| Registration Date | Tuesday, November 29, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 13, 2022 |
| Goods and Services | Custom manufacture of pharmaceuticals; processing of pharmaceuticals, namely treatment in the nature of chemical processing of chemical, biochemical and pharmaceutical products for third parties; custom manufacturing services in the nature of processing of pharmaceutical preparations; processing of pharmaceutical preparations, assembly of products for others, namely, processing of pharmaceuticals, medicines, and biological preparations to the order and specification of others; treatment in the nature of chemical processing of chemical, biochemical and pharmaceutical products for third parties; treatment of materials, namely, pharmaceutical, biologic, and chemical products and their components used in the manufacture of pharmaceuticals, biotherapeutic products, and biopharmaceuticals; treatment and destruction of pharmaceutical waste; information, advice and consultancy services in relation to the aforesaid services |
| Goods and Services | Pharmaceuticals, namely, psychotropics, antihelmintics, anti-infectives, lipid lowering agents, inducers of erections, induction agents, neuromuscular blocking agents, sedatives, anti-cancer medication, anti-inflammatories, anti-fungals, anti-bacterials, anti-spasmodics, appetite stimulants, bronchodilators, appetite suppressants, anti-convulsives, neuroprotective drugs, anti-anxiety medication, anti-depressants, anti-ischemics, anti-psychotics; pharmaceutical preparations for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; Pharmaceuticals, namely, pharmaceutical preparations and substances for the treatment of viral, infectious, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for medical or veterinary purposes; vaccines; medicine for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, and rare ear, nose, and throat diseases; chemical preparations for use in the pharmaceutical industry, namely for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury |
| Goods and Services | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diabetes, ear, nose and throat disorders, epilepsy, genetic disorders, hematological disorders, hormonal disorders, infectious diseases, lymphoma, metabolic disorders, mouth and dental disorders, musculoskeletal disorder, non-malignant disorder, nutritional disorders, pain, rare ophthalmological diseases, rare cancers, rare infectious diseases, rare genetic diseases, rare respiratory diseases, rare central nervous system diseases, rare gastrointestinal diseases, rare immunological diseases, rare cardiovascular diseases, rare dermatological diseases, rare urinary system and sex hormone diseases, rare womens health diseases, rare ear, nose, and throat diseases, animal health disorders, cardiovascular diseases and disorders, central nervous system disorders, dermatologic disorders, endocrine system disorders, gastrointestinal diseases, genito urinary system and sex hormone imbalances, male health disorders, women's health disorders, mental health disorders, musculoskeletal disorders, renal disorders, cancer, ophthalmic disorders, renal diseases, respiratory diseases, trauma and injury |
| Goods and Services | Pharmaceutical research services; pharmaceutical drug development services; pharmaceutical design services, namely, shaping and designing pills; testing of pharmaceuticals; conducting clinical trials for others relating to pharmaceuticals and chemicals; pharmaceutical analysis, namely, chemical composition analysis, testing, analysis, and evaluation of pharmaceuticals to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; inspection of pharmaceuticals; biological research services; quality control and authentication services for others in the field of pharmaceuticals; information, advice and consultancy services in relation to the aforesaid services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 2, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 2, 2022 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 2, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Sterling Pharma Solutions Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Northumberland NE237QG GB |
| Party Name | Sterling Pharma Solutions Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Northumberland NE237QG GB |
| Party Name | Sterling Pharma Solutions Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Northumberland NE237QG GB |
| Event Date | Event Description |
| Tuesday, November 29, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 29, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 13, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 24, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 5, 2022 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, August 2, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 2, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 2, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 2, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 2, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 27, 2022 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, July 27, 2022 | WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST |
| Friday, July 22, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 19, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 19, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 19, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 19, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, June 30, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 30, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 30, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, January 24, 2022 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, January 24, 2022 | FINAL REFUSAL E-MAILED |
| Monday, January 24, 2022 | FINAL REFUSAL WRITTEN |
| Tuesday, December 28, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 28, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 28, 2021 | ASSIGNED TO LIE |
| Thursday, December 23, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, June 25, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 25, 2021 | NON-FINAL ACTION E-MAILED |
| Friday, June 25, 2021 | NON-FINAL ACTION WRITTEN |
| Monday, June 21, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, March 10, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, December 26, 2020 | NEW APPLICATION ENTERED IN TRAM |